Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasm Metastasis
×
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
×
Clear all
Filters
3
NCT03654729
2021-12-17
POLAR-M
Egetis Therapeutics
Phase 3
Terminated
291 enrolled
20 charts